Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 11, Issue 1, Pages 42-57
Publisher
Elsevier BV
Online
2022-12-06
DOI
10.1016/s2213-8587(22)00319-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized comparison of initiating the fixed-ratio combination of iGlarLixi or biosimilar insulin glargine together with gliclazide in South Asian origin participants with Type 2 Diabetes: VARIATION 2 SA trial
- (2022) Harpreet S. Bajaj et al. Canadian Journal of Diabetes
- Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin
- (2022) Fernando Gomez‐Peralta et al. DIABETES OBESITY & METABOLISM
- Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
- (2022) Satish Garg et al. Diabetes Technology & Therapeutics
- Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes
- (2022) Federico Boscari et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study
- (2022) Jean-Pierre Riveline et al. Diabetes Technology & Therapeutics
- Real-time CGM can predict severe hypoglycemia in people with type 1 diabetes: combined analysis of the HypoDE and DIAMOND trials
- (2022) Norbert Hermanns et al. Diabetes Technology & Therapeutics
- Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- (2022) Tadej Battelino et al. Lancet Diabetes & Endocrinology
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
- (2022) David C. Klonoff et al. Journal of diabetes science and technology
- Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes
- (2022) Eslam Montaser et al. Diabetes Technology & Therapeutics
- The Optimal Duration of a Run-in Period to Initiate Continuous Glucose Monitoring for a Randomized Trial
- (2022) Dan Raghinaru et al. Diabetes Technology & Therapeutics
- CGM‐based Time‐in‐Range Using Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Type 1 Diabetes: The Head‐to‐Head Randomized Controlled InRange Trial
- (2022) Tadej Battelino et al. DIABETES OBESITY & METABOLISM
- Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
- (2022) Moshe Phillip et al. ENDOCRINE REVIEWS
- Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes
- (2022) Lalantha Leelarathna et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in HbA1c and Quality of Life with Real-time CGM Use by People with Insulin-Treated Diabetes in the Landmark Study
- (2021) Timothy Gilbert et al. Diabetes Technology & Therapeutics
- Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020
- (2021) Joost van der Linden et al. Diabetes Technology & Therapeutics
- Important Drop Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study
- (2021) Ronan Roussel et al. DIABETES CARE
- Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews
- (2021) Ana Díez-Fernández et al. International Journal of Environmental Research and Public Health
- Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia
- (2021) Ronald M. Goldenberg et al. DIABETES OBESITY & METABOLISM
- Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
- (2021) Nunzio Camerlingo et al. DIABETES OBESITY & METABOLISM
- Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study
- (2021) Satish K. Garg et al. Diabetes Technology & Therapeutics
- Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations
- (2021) Timothy S. Bailey et al. Diabetes Technology & Therapeutics
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
- (2021) Thomas Martens et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes
- (2021) Barbora Paldus et al. DIABETES CARE
- Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial
- (2021) Sybil A. McAuley et al. DIABETES CARE
- Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
- (2021) Roy W. Beck et al. Diabetes Technology & Therapeutics
- The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2021) Richard I. G. Holt et al. DIABETOLOGIA
- Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial
- (2021) Wendy S. Lane et al. Endocrine Practice
- Glycaemic management in diabetes: old and new approaches
- (2021) Antonio Ceriello et al. Lancet Diabetes & Endocrinology
- Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study
- (2021) Ignacio Conget et al. Diabetes Therapy
- Interferences With CGM Systems: Practical Relevance?
- (2021) Lutz Heinemann Journal of diabetes science and technology
- More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data
- (2021) Richard M. Bergenstal et al. Journal of diabetes science and technology
- Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes
- (2021) Richard M. Bergenstal et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Baseline Glucose Variability and Interweek Variability Affects the Time to Stability of Continuous Glucose Monitoring-Derived Glycemic Indices
- (2020) Suresh Rama Chandran et al. Diabetes Technology & Therapeutics
- TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes
- (2020) Fengwen Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glycemic variability – the danger of a physiologically stable metric
- (2020) Tadej Battelino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of the FreeStyle Libre TM Flash Glucose Monitoring System on Glycemic Control in Subjects with Type 2 Diabetes Treated with Basal‐Bolus Insulin Therapy: An Open Label, Prospective, Multicenter Trial in Japan
- (2020) Wataru Ogawa et al. Journal of Diabetes Investigation
- Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial
- (2020) Eri Wada et al. BMJ Open Diabetes Research & Care
- Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
- (2020) Jingyi Lu et al. DIABETES CARE
- Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycaemic control
- (2020) Pau Herrero et al. Diabetes Technology & Therapeutics
- Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
- (2020) Junpeng Yang et al. Journal of Diabetes Investigation
- HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis
- (2020) Jordan E. Perlman et al. Diabetes Technology & Therapeutics
- Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study
- (2019) Viral N Shah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study
- (2019) Jan Šoupal et al. DIABETES CARE
- Time in range is associated with carotid intima-media thickness in type 2 diabetes
- (2019) Jingyi Lu et al. Diabetes Technology & Therapeutics
- Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
- (2019) Sara Charleer et al. DIABETES CARE
- Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice
- (2018) Ramzi A Ajjan et al. Diabetes & Vascular Disease Research
- Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests
- (2018) Timothy C. Dunn et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System
- (2018) Carrie Lorenz et al. Diabetes Technology & Therapeutics
- Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
- (2018) Tonya D. Riddlesworth et al. Diabetes Technology & Therapeutics
- Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes
- (2018) R. Paul Wadwa et al. Diabetes Technology & Therapeutics
- Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator
- (2018) Viral N. Shah et al. Diabetes Technology & Therapeutics
- A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices
- (2018) Satish K. Garg et al. Diabetes Technology & Therapeutics
- iHART: methodological inconsistency precludes hypoglycemia conclusions
- (2018) A Seibold et al. DIABETIC MEDICINE
- Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study
- (2018) Sara Charleer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
- (2018) Richard M. Bergenstal et al. DIABETES CARE
- Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting
- (2018) Eric Renard et al. DIABETES OBESITY & METABOLISM
- Reply to Seibold and Schlaeger iHART: methodological inconsistency precludes hypoglycaemia conclusions
- (2018) N. Oliver et al. DIABETIC MEDICINE
- Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
- (2018) Linda A. DiMeglio et al. PEDIATRIC DIABETES
- Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study
- (2018) Fiona M. Campbell et al. PEDIATRIC DIABETES
- Real-time intradermal continuous glucose monitoring using a minimally invasive microneedle-based system
- (2018) Federico Ribet et al. BIOMEDICAL MICRODEVICES
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
- (2017) Marcus Lind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
- (2017) Roy W. Beck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metrics for glycaemic control — from HbA1c to continuous glucose monitoring
- (2017) Boris P. Kovatchev Nature Reviews Endocrinology
- Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial
- (2017) Roy W Beck et al. Lancet Diabetes & Endocrinology
- Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
- (2017) Tonya Riddlesworth et al. Diabetes Therapy
- Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections
- (2017) Tonya Riddlesworth et al. Diabetes Therapy
- Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial
- (2016) Jort Kropff et al. DIABETES CARE
- Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
- (2016) Louis Monnier et al. DIABETES CARE
- Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
- (2016) Jan Bolinder et al. LANCET
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
- (2016) Thomas Haak et al. Diabetes Therapy
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
- (2016) Thomas Haak et al. Diabetes Therapy
- Performance of 10 Systems for Self-Monitoring of Blood Glucose by Trained Healthcare Professionals and in the Hands of the Users
- (2015) U. O. Solvik et al. CLINICAL CHEMISTRY
- Effect of Acetaminophen on CGM Glucose in an Outpatient Setting: Figure 1
- (2015) David M. Maahs et al. DIABETES CARE
- The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
- (2015) Timothy Bailey et al. Diabetes Technology & Therapeutics
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
- (2013) Richard M. Bergenstal et al. Diabetes Technology & Therapeutics
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
- (2012) T. Battelino et al. DIABETOLOGIA
- Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
- (2011) Dongyuan Xing et al. Diabetes Technology & Therapeutics
- Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial
- (2009) DIABETES CARE
- Hyperglycemic Crises in Adult Patients With Diabetes
- (2009) A. E. Kitabchi et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started